参考文献/References:
[1] Shi TY,Zhang FC.Role of autoimmunity in primary biliary cirrhosis[J].World Journal of Gastroenterology,2012,18(48):7141-7148.
[2] Webb GJ,Siminovitch KA,Hirschfield GM.The immunogenetics of primary biliary cirrhosis:A comprehensive review[J].Journal of Autoimmunity,2015,64:42-52.
[3] Hirschfield GM,Gershwin ME.The immunobiology and pathophysiology of primary biliary cirrhosis[J].Annual Review of Pathology,2013(8):303-30.
[4] Fenoglio D,Bernuzzi F,Battaglia F,et al.Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmunefibrotic diseases[J].Autoimmunity Reviews,2012,12(2):300-304.
[5] Santodomingo-Garzon T,Swain MG.Role of NKT cells in autoimmune liver disease[J].Autoimmunity Reviews,2011,10(12):793-800.
[6] Dai S,Jia R,Zhang X,et al.The PD-1/PD-Ls pathway and autoimmune diseases[J].Cellular Immunology,2014,290(1):72-79.
[7] Ou JN,Wiedeman AE,Stevens AM.TNF-α and TGF-β counter-regulate PD-L1 expression on monocytes in systemic lupus erythematosus[J].Scientific Reports,2012(2):295.
[8] Pittet CL,Newcombe J,Prat A,et al.Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis[J].Journal of Neuroinflammation,2011(8):155.
[9] 李 虎,陈 燕,张 蕾,等.原发性胆汁性肝硬化患者外周血Th9细胞表达增高及临床意义[J].现代检验医学杂志,2016,31(3):16-18,21.
Li H,Chen Y,Zhang L,et al.Expression of Th9 cells from peripheral blood of primary biliary cirrhosis patients and its clinical significance[J].J Mod Lab Med,2016,31(3):16-18,21.
[10] Herold M,Posevitz V,Chudyka D,et al.B7-H1 selectively controls TH17 differentiation and central nervous system autoimmunity via a novel non-PD-1-mediated pathway[J].Journal of Immunology,2015,195(8):3584-3595.
[11] Greisen SR,Rasmussen TK, Stengaard-Pedersen K,et al.Increased soluble programmed death-1(sPD-1)is associated with disease activity and radiographic progression in early rheumatoid arthritis[J].Scandinavian Journal of Rheumatology,2014,43(2):101-108.
[12] Jaworska K,Ratajczak J,Huang L,et al.Both PD-1 ligands protect thekidney from ischemia reperfusion injury[J].Journal of Immunology,2015,194(1):325-333.
相似文献/References:
[1]钱 琤,谷明莉,陈 燕,等.原发性胆汁性肝硬化患者外周血单个核细胞IL-23p19表达增高及意义[J].现代检验医学杂志,2016,31(02):20.[doi:10.3969/j.issn.1671-7414.2016.02.006]
QIAN Cheng,GU Ming-li,CHEN Yan,et al.High Expression of IL-23p19 in Peripheral Blood Mononuclear Cells
of Patients with Primary Biliary Cirrhosis and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2016,31(05):20.[doi:10.3969/j.issn.1671-7414.2016.02.006]
[2]陈 燕a,谷明莉a,叶 辛b,等.STING在原发性胆汁性肝硬化患者
外周血单个核细胞中的表达及临床意义[J].现代检验医学杂志,2016,31(03):33.[doi:10.3969/j.issn.1671-7414.2016.03.010]
CHEN Yana,GU Ming-lia,YE Xinb,et al.Expression of STING in Peripheral Blood in Patients
with Primary Biliary Cirrhosis and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2016,31(05):33.[doi:10.3969/j.issn.1671-7414.2016.03.010]
[3]李腾达,刘挺挺,吴林洪,等.原发性胆汁性肝硬化患者外周血单个核细胞中Tim-1表达增高及其意义[J].现代检验医学杂志,2016,31(04):41.[doi:10.3969/j.issn.16717-414.2016.04.010]
LI Teng-da,LIU Ting-ting,WU Lin-hong,et al.Increasing Expression of Tim-1 in Peripheral Blood Mononuclear
Cell of Patients with Primary Biliary Cirrhosis and Its Significance[J].Journal of Modern Laboratory Medicine,2016,31(05):41.[doi:10.3969/j.issn.16717-414.2016.04.010]
[4]刘挺挺a,谷明莉a,张 蕾a,等.原发性胆汁性肝硬化患者外周血中性粒细胞/淋巴细胞比值及其临床意义[J].现代检验医学杂志,2016,31(05):127.[doi:10.3969/j.issn.1671-7414.2016.05.036]
LIU Ting-tinga,GU Ming-lia,ZHANG Leia,et al.Clinical Significance of Neutrophils/Lymphocyte of Peripheral
Blood in Patients with Primary Biliary Cirrhosis[J].Journal of Modern Laboratory Medicine,2016,31(05):127.[doi:10.3969/j.issn.1671-7414.2016.05.036]
[5]李腾达,陈 燕,龙曙萍,等.原发性胆汁性肝硬化患者外周血单个核细胞中IL-37表达增高及临床意义[J].现代检验医学杂志,2017,32(01):12.[doi:10.3969/j.issn.1671-7414.2017.01.004]
LI Teng-da,CHEN Yan,LONG Shu-ping,et al.Increasing Expression of IL-37 in Peripheral Blood Mononuclear Cell
of Patients with Primary Biliary Cirrhosis and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(05):12.[doi:10.3969/j.issn.1671-7414.2017.01.004]